| Authors: |
Camidge DR; Department of Medicine, University of Colorado Cancer Center, Aurora, Colorado. Electronic address: ross.camidge@cuanschutz.edu., Kim HR; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Ahn MJ; Division of Hematology-Oncology, Samsung Medical Center, Seoul, South Korea., Yang JCH; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan., Han JY; Department of Precision Medicine, National Cancer Center, Gyeonggi, South Korea., Hochmair MJ; Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Vienna, Austria., Lee KH; Internal Medicine Department, Chungbuk National University Hospital, Chungbuk, South Korea., Delmonte A; Department of Medical Oncology, Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Meldola, Italy., Garcia Campelo MR; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña (CHUAC), University Hospital A Coruña, A Coruña, Spain., Kim DW; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea., Griesinger F; Department of Hematology and Oncology, Pius-Hospital Oldenburg, University of Oldenburg, Oldenburg, Germany., Felip E; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Califano R; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom; Department of Medical Oncology, Division of Cancer Sciences, The University of Manchester, Manchester, England, United Kingdom., Spira AI; Department of Medical Oncology, Virginia Cancer Specialists, US Oncology Research, Fairfax, Virginia., Gettinger SN; Department of Medical Oncology, Yale Cancer Center, New Haven, Connecticut., Tiseo M; Department of Medicine and Surgery, University Hospital of Parma, Parma, Italy., Lin HM; Global Evidence and Outcome, Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Liu Y; Oncology Statistics, Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Vranceanu F; Clinical Science, Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Niu H; Oncology Translational Sciences, Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Zhang P; Oncology Clinical Research, Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Popat S; Royal Marsden Hospital, London, United Kingdom. |
